Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Nurs Educ ; 60(4): 196-202, 2021 Apr.
Article in English | MEDLINE | ID: mdl-34038277

ABSTRACT

BACKGROUND: Nursing students need to learn about sleep health to provide safe patient care. The purpose of this study was to investigate sleep in nursing students and describe factors that affect their sleep. METHOD: This study used a cross-sectional descriptive design with a convenience sample from baccalaureate nursing programs in a midwestern region of the United States. Data were collected using a demographic questionnaire, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Sleep Hygiene Index. RESULTS: Two hundred fifty-four nursing students reported poor sleep quality, excessive daytime sleepiness, and maladaptive sleep hygiene, regardless of their year of study or enrollment status. Behavior of technology use into the night was the most frequent reason why students lost sleep. CONCLUSION: Learning the importance of sleep hygiene, good sleep quality, and the associated health benefits may assist nursing students with achieving optimal daytime functioning. Consideration should be given to sleep health content as a thread through nursing curriculum. [J Nurs Educ. 2021;60(4):196-202.].


Subject(s)
Sleep , Students, Nursing , Cross-Sectional Studies , Disorders of Excessive Somnolence/epidemiology , Humans , Students, Nursing/statistics & numerical data , Surveys and Questionnaires
2.
Blood ; 104(5): 1344-9, 2004 Sep 01.
Article in English | MEDLINE | ID: mdl-15126322

ABSTRACT

We have generated transgenic mice expressing the leech anticoagulant hirudin and human tissue factor pathway inhibitor tethered to the cell surface by fusion with fragments of human CD4 and P-selectin. Expression of the transgenes is under the control of the CD31 (platelet endothelial cell adhesion molecule [PECAM]) promoter, limiting expression to endothelial cells, monocytes, and platelets. In addition, the P-selectin sequence directs expression to secretory granules. Functional cell surface expression only occurs when the cells are activated. In a mouse model of systemic lipopolysaccharide (LPS)-induced endotoxemia, we show that expression of either anticoagulant on activated endothelium inhibits the widespread intravascular thrombosis, thrombocytopenia, and consumptive coagulopathy associated with endotoxemia. Importantly, non- LPS-treated transgenic mice had normal baseline bleeding times. We speculate that targeted delivery of anticoagulants to the endothelium may be a strategy worth pursuing in clinical sepsis to improve efficacy of systemic anticoagulation while minimizing potential hemorrhagic side effects.


Subject(s)
Endotoxemia/therapy , Genetic Therapy/methods , Hirudins/genetics , Lipoproteins/genetics , Thrombosis/therapy , Animals , Bone Marrow/physiology , Disease Models, Animal , Endotoxemia/complications , Endotoxemia/pathology , Humans , Leeches , Mice , Mice, Transgenic , Recombinant Fusion Proteins/genetics , Thrombosis/etiology , Thrombosis/pathology
3.
Science ; 299(5605): 411-4, 2003 Jan 17.
Article in English | MEDLINE | ID: mdl-12493821

ABSTRACT

The enzyme alpha1,3-galactosyltransferase (alpha1,3GT or GGTA1) synthesizes alpha1,3-galactose (alpha1,3Gal) epitopes (Galalpha1,3Galbeta1,4GlcNAc-R), which are the major xenoantigens causing hyperacute rejection in pig-to-human xenotransplantation. Complete removal of alpha1,3Gal from pig organs is the critical step toward the success of xenotransplantation. We reported earlier the targeted disruption of one allele of the alpha1,3GT gene in cloned pigs. A selection procedure based on a bacterial toxin was used to select for cells in which the second allele of the gene was knocked out. Sequencing analysis demonstrated that knockout of the second allele of the alpha1,3GT gene was caused by a T-to-G single point mutation at the second base of exon 9, which resulted in inactivation of the alpha1,3GT protein. Four healthy alpha1,3GT double-knockout female piglets were produced by three consecutive rounds of cloning. The piglets carrying a point mutation in the alpha1,3GT gene hold significant value, as they would allow production of alpha1,3Gal-deficient pigs free of antibiotic-resistance genes and thus have the potential to make a safer product for human use.


Subject(s)
Galactosyltransferases/deficiency , Galactosyltransferases/genetics , Gene Targeting , Point Mutation , Swine/genetics , Trisaccharides/analysis , Alleles , Animals , Bacterial Toxins/pharmacology , Cell Line , Cloning, Molecular , Cloning, Organism , DNA, Complementary , Embryo Transfer , Enterotoxins/pharmacology , Female , Fibroblasts , Genetic Vectors , HeLa Cells , Humans , Immunoglobulin M/blood , Islets of Langerhans Transplantation , Mice , Mice, Knockout , Pregnancy , Transfection , Transplantation, Heterologous , Trisaccharides/biosynthesis , Trisaccharides/immunology
4.
Traffic ; 3(10): 718-29, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12230470

ABSTRACT

Macrophages are important targets for HIV-1 infection and harbor the virions in an as yet unidentified organelle. To determine the location of HIV-1 in these cells, an extensive analysis of primary human macrophages infected in vitro with HIV-1 was carried out by immuno-electron microscopy. Virus particles were found to accumulate in intracellular multivesicular compartments which were enriched in major histocompatibility complex class II molecules and CD63. These features are characteristics of major histocompatibility complex class II compartments where maturing class II molecules acquire their peptide cargo. The membrane-delimited, electron-dense virus particles of 100-110 nm diameter labeled strongly for HIV-1 p24 antigen, major histocompatibility complex class II molecules, CD63 and, to a lesser extent for HIV-1 gp120 envelope protein and Lamp 1. Our data suggest that virus particles may access the lumen of the major histocompatibility complex class II compartment by budding from the limiting membrane, thus acquiring proteins of this membrane such as class II and CD63. Viral assembly and budding would therefore occur in macrophages by a process similar to the formation of the internal vesicles in multivesicular bodies and at the same location. This could account for the particular content in lipids and proteins previously found in the membrane wrapping HIV particles. Our observations also suggest direct fusion of the virus containing major histocompatibility complex class II compartment with the plasma membrane, leading to massive release of viral particles into the extracellular medium.


Subject(s)
HIV-1/isolation & purification , Histocompatibility Antigens Class II/immunology , Macrophages/virology , Cell Compartmentation , HIV-1/immunology , HIV-1/physiology , Humans , Membrane Fusion
SELECTION OF CITATIONS
SEARCH DETAIL
...